Weill David
SEC CIK 1774270 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TMDX | TransMedics Group, Inc. | Dir | 16.4K | $264.1K | $3.47M | 17 | 2022-11-10 | 2026-09-11 |
Most active insiders at TMDX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Weill David | Dir | $109.1K | $1.22M |
| 2 | Hernandez Gerardo | CFO | — | $1.25M |
| 3 | Hassanein Waleed H | Pres, CEO, Dir | $1.00M | — |
| 4 | Gunderson Thomas J. | Dir | — | $722.4K |
| 5 | Ranganath Anil P. | See remarks | — | $555.9K |
| 6 | Basile Edward M | Dir | — | $540.3K |
| 7 | Corcoran Nicholas | See remarks | — | $412.6K |
| 8 | Lovell Stephanie | Dir | — | $178.5K |
| 9 | Forsyth Matthew S. | See Remarks | — | — |
| 10 | Cecere Giovanni | Chief Commercial Off | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 16:30 | 2026-09-11 | TMDX | TransMedics Group, Inc. | Weill David | Dir | P - Purchase | $81.63 | +1,336 | 16.4K | +9% | +$109.1K | |
| 2026-05-22 16:15 | 2026-05-20 | TMDX | TransMedics Group, Inc. | Weill David | Dir | A - Grant | $0.00 | +2,922 | 15.1K | +24% | $0 | |
| D | 2026-03-06 | 2026-03-04 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale+OE | $146.82 | -3,571 | 12.1K | -23% | -$524.3K |
| D | 2026-03-06 | 2026-03-04 | TMDX | TransMedics Group, Inc. | Weill David | Dir | M - OptEx | $14.20 | +3,571 | 15.7K | +29% | +$50.7K |
| D | 2025-12-05 | 2025-12-03 | TMDX | TransMedics Group, Inc. | Weill David | Dir | M - OptEx | $14.20 | +5,000 | 17.1K | +41% | +$71.0K |
| D | 2025-12-05 | 2025-12-03 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale+OE | $138.64 | -5,000 | 12.1K | -29% | -$693.2K |
| 2025-05-23 | 2025-05-23 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale | $123.88 | -732 | 12.1K | -6% | -$90.7K | |
| 2025-05-23 | 2025-05-22 | TMDX | TransMedics Group, Inc. | Weill David | Dir | A - Grant | $0.00 | +2,134 | 12.9K | +20% | $0 | |
| 2024-05-31 | 2024-05-29 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale | $141.65 | -1,193 | 10.7K | -10% | -$169.0K | |
| D | 2024-05-28 | 2024-05-23 | TMDX | TransMedics Group, Inc. | Weill David | Dir | A - Grant | $0.00 | +732 | 11.9K | +7% | $0 |
| 2024-05-14 | 2024-05-10 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale | $129.82 | -2,500 | 11.2K | -18% | -$324.6K | |
| 2023-08-30 | 2023-08-29 | TMDX | TransMedics Group, Inc. | Weill David | Dir | P - Purchase | $62.00 | +2,500 | 13.7K | +22% | +$155.0K | |
| D | 2023-05-30 | 2023-05-25 | TMDX | TransMedics Group, Inc. | Weill David | Dir | A - Grant | $0.00 | +1,193 | 11.2K | +12% | $0 |
| DM | 2023-02-28 | 2023-02-27 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale+OE | $76.69 | -5,934 | 15.0K | -28% | -$455.1K |
| D | 2023-02-28 | 2023-02-27 | TMDX | TransMedics Group, Inc. | Weill David | Dir | M - OptEx | $14.20 | +5,934 | 15.9K | +59% | +$84.3K |
| D | 2022-11-14 | 2022-11-10 | TMDX | TransMedics Group, Inc. | Weill David | Dir | S - Sale+OE | $56.00 | -21.6K | 13.5K | -62% | -$1.21M |
| D | 2022-11-14 | 2022-11-10 | TMDX | TransMedics Group, Inc. | Weill David | Dir | M - OptEx | $16.00 | +21.6K | 35.1K | +160% | +$346.3K |
Purchase Sale Sale after option exercise All abbreviations